{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:55:17Z","timestamp":1795085717284,"version":"4.10.2"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,16]]},"abstract":"<jats:p>Various factors can affect the survival of patients with oropharyngeal cancer. We assessed the expression of protein p16INK4a, Flotillin2, epidermal growth factor receptor, and other clinicopathological features and their prognostic value for this type of cancer. We gathered patient data on demographics, clinicopathological characteristics, treatment patterns, and outcomes. Histologically and by immunochemistry staining we determined expression of prognostic factors and molecular biomarkers. The primary endpoints were overall survival (OS), disease-specific survival (DSS), and disease-free survival (DFS). Survival was assessed using the Kaplan\u2013Meier method and Cox regression model analyses of potential prognostic parameters. After a median follow-up of 78 months, the median OS was 41 months, with an event recorded in 77.8% of patients. Median DFS was 22 months, 37 patients (51.4%) had disease relapse. The DSS survival rate was 58.3% with a median survival of 68 months. In regards to molecular biomarkers previously mentioned, there was no statistical significance for survival categories. After conducting a multivariate analysis of significant variables, we found that only recurrence, vascular invasion, and surgical intervention remained as factors with independent effects on both OS and DFS. Recurrence and the N stage were identified as independent prognostic factors for DSS. Our analysis underscores the complexity of factors that collectively influence survival following the diagnosis of OPSCC. Several factors were found to be statistically significant. These factors included the type of surgical procedure, disease relapse, vascular invasion, lymphatic invasion, perineural invasion, advanced T stage of the disease, N stage of the disease, and smoking status. The significance of these factors may vary across different types of survival. This analysis did not find any significant impact on survival from the growth factors tested, namely epidermal growth factor receptor, Flotillin2, and p16INK4a, in the applied regression models.<\/jats:p>","DOI":"10.1097\/md.0000000000038894","type":"journal-article","created":{"date-parts":[[2024,8,17]],"date-time":"2024-08-17T00:01:23Z","timestamp":1723852883000},"page":"e38894","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Expression of p16INK4a, FLOT2, and EGFR in oropharyngeal carcinoma, prognostic significance and correlation with clinicopathological characteristics"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7820-8176","authenticated-orcid":false,"given":"Dejan","family":"\u0110okanovi\u0107","sequence":"first","affiliation":[{"name":"Oncology Clinic, University Clinical Center of the Republic of Srpska, Banja Luka, Republic of Srpska, Bosnia and Herzegovina"},{"name":"Faculty of Medicine, University of Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radoslav","family":"Gajanin","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenka","family":"Gojkovi\u0107","sequence":"additional","affiliation":[{"name":"Oncology Clinic, University Clinical Center of the Republic of Srpska, Banja Luka, Republic of Srpska, Bosnia and Herzegovina"},{"name":"Faculty of Medicine, University of Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semir","family":"Kloki\u0107","sequence":"additional","affiliation":[{"name":"Gruppenpraxis Laufen, General Practioners Office, Basel-Country, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Sladojevi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Gajanin","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragana","family":"Relji\u0107","sequence":"additional","affiliation":[{"name":"Oncology Clinic, University Clinical Center of the Republic of Srpska, Banja Luka, Republic of Srpska, Bosnia and Herzegovina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olja","family":"Jovi\u0107-\u0110okanovi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina"},{"name":"Infectology Cllinic, University Clinical Center of the Republic of Srpska, Banja Luka, Republic of Srpska, Bosnia and Herzegovina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljiljana","family":"Amid\u017ei\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goran","family":"Maro\u0161evi\u0107","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Banja Luka, Banja Luka, Republic of Srpska, Bosnia and Herzegovina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study.","volume":"5","author":"Fitzmaurice","year":"2019","journal-title":"JAMA Oncol"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2015.61.6995","article-title":"Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma.","volume":"33","author":"Gillison","year":"2015","journal-title":"J Clin Oncol"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.joms.2017.05.008","article-title":"Epidemiological trends of head and neck cancer in the United States: a SEER population study.","volume":"75","author":"Mourad","year":"2017","journal-title":"J Oral Maxillofac Surg"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study.","volume":"3","author":"Fitzmaurice","year":"2017","journal-title":"JAMA Oncol"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States.","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"key":"R6-20250503","first-page":"146","article-title":"Up-regulation of Flot-2 protein is related to lymph node metastasis and poor prognosis in human solid tumors.","volume":"72","author":"Liu","year":"2017","journal-title":"Minerva Chir"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/cells3010129","article-title":"Flotillins in receptor tyrosine kinase signaling and cancer.","volume":"3","author":"Banning","year":"2014","journal-title":"Cells"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1186\/1743-422X-8-479","article-title":"Research advances on flotillins.","volume":"8","author":"Zhao","year":"2011","journal-title":"Virol J"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1631\/jzus.B1700102","article-title":"Roles of flotillins in tumors.","volume":"19","author":"Liu","year":"2018","journal-title":"J Zhejiang Univ Sci B"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cca.2018.02.036","article-title":"Prognostic value of flotillins (flotillin-1 and flotillin-2) in human cancers: a meta-analysis.","volume":"481","author":"Deng","year":"2018","journal-title":"Clin Chim Acta"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"e101676","DOI":"10.1371\/journal.pone.0101676","article-title":"Increased expression of flotillin-2 protein as a novel biomarker for lymph node metastasis in nasopharyngeal carcinoma.","volume":"9","author":"Wen","year":"2014","journal-title":"PLoS One"},{"key":"R12-20250503","first-page":"8236","article-title":"FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma.","volume":"8","author":"Wen","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/35052073","article-title":"Untangling the ErbB signalling network.","volume":"2","author":"Yarden","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.radonc.2013.08.036","article-title":"Expression of EGFR and HPV-associated p16 in oropharyngeal carcinoma: correlation and influence on prognosis after radiotherapy in the randomized DAHANCA 5 and 7 trials.","volume":"108","author":"Lassen","year":"2013","journal-title":"Radiother Oncol"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1200\/JCO.2007.12.7662","article-title":"EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer.","volume":"26","author":"Kumar","year":"2008","journal-title":"J Clin Oncol"},{"key":"R16-20250503","first-page":"153","article-title":"Intense CD44 expression is a negative prognostic factor in tonsillar and base of tongue cancer.","volume":"32","author":"Lindquist","year":"2012","journal-title":"Anticancer Res"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.oraloncology.2014.02.001","article-title":"Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer.","volume":"50","author":"Vainshtein","year":"2014","journal-title":"Oral Oncol"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40463-018-0323-6","article-title":"EGFR as a biomarker of smoking status and survival in oropharyngeal squamous cell carcinoma.","volume":"48","author":"Sivarajah","year":"2019","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"R19-20250503","article-title":"Guidelines Head and Neck Cancers."},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11912-019-0799-x","article-title":"Changes in the 8th edition of the American Joint Committee on Cancer (AJCC) staging of head and neck cancer: rationale and implications.","volume":"21","author":"Zanoni","year":"2019","journal-title":"Curr Oncol Rep"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12957-018-1425-3","article-title":"Immunohistochemical expression of epidermal growth factor receptor (EGFR) in South Asian head and neck squamous cell carcinoma: association with various risk factors and clinico-pathologic and prognostic parameters.","volume":"16","author":"Hashmi","year":"2018","journal-title":"World J Surg Onc"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"815","DOI":"10.21873\/invivo.11544","article-title":"Combined EGFR\/ALK expression analysis in laryngeal squamous cell carcinoma.","volume":"33","author":"Politi","year":"2019","journal-title":"In Vivo"},{"key":"R24-20250503","first-page":"1","article-title":"Association of p16 as Prognostic Factors for Oropharyngeal Cancer: Evaluation of p16 in 1470 Patients for a 16 Year Study in Northeast China.","volume":"2018","author":"Meng","year":"2018","journal-title":"BioMed Research International"},{"key":"R25-20250503","first-page":"m10","article-title":"Demographic and clinicopathologic distribution of oral cavity and oropharyngeal cancer in Alberta, Canada: a comparative analysis.","volume":"88","author":"Ganatra","year":"2022","journal-title":"J Can Dent Assoc"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.oraloncology.2010.07.015","article-title":"Alcohol drinking and laryngeal cancer: overall and dose-risk relation \u2013 a systematic review and meta-analysis.","volume":"46","author":"Islami","year":"2010","journal-title":"Oral Oncol"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.prro.2017.02.002","article-title":"Radiation therapy for oropharyngeal squamous cell carcinoma: executive summary of an ASTRO evidence-based clinical practice guideline.","volume":"7","author":"Sher","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2004.08.021","article-title":"Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma.","volume":"22","author":"Denis","year":"2004","journal-title":"J Clin Oncol"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/hed.21669","article-title":"Transoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study.","volume":"33","author":"Haughey","year":"2011","journal-title":"Head Neck"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijom.2021.03.007","article-title":"Lymphovascular invasion as a prognostic tool for oral squamous cell carcinoma: a comprehensive review.","volume":"51","author":"Mascitti","year":"2022","journal-title":"Int J Oral Maxillofac Surg"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"100028","DOI":"10.1016\/j.oor.2023.100028","article-title":"Challenges seen with peri-neural invasion in head and neck cancer \u2013 a review article.","volume":"6","author":"Purohit","year":"2023","journal-title":"Oral Oncol Rep"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1177\/000348949710601117","article-title":"Pretreatment pathologic prognostic factors in head and neck squamous cell carcinoma.","volume":"106","author":"Devaney","year":"1997","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/archotol.124.6.637","article-title":"Perineural invasion in squamous cell carcinoma of the head and neck.","volume":"124","author":"Fagan","year":"1998","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.","volume":"100","author":"Fakhry","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1093\/annonc\/mdt319","article-title":"Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials.","volume":"24","author":"Rietbergen","year":"2013","journal-title":"Ann Oncol"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer.","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/cncr.33370","article-title":"Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis.","volume":"127","author":"Dahlstrom","year":"2021","journal-title":"Cancer"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"20190464","DOI":"10.1259\/bjr.20190464","article-title":"Analyzing oropharyngeal cancer survival outcomes: a decision tree approach.","volume":"93","author":"De Felice","year":"2020","journal-title":"Br J Radiol"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"5815493","DOI":"10.1155\/2017\/5815493","article-title":"Low survival rates of oral and oropharyngeal squamous cell carcinoma.","volume":"2017","author":"Le Campion","year":"2017","journal-title":"Int J Dent"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10006-021-00986-4","article-title":"Five-year survival and prognostic factors for oropharyngeal squamous cell carcinoma: retrospective cohort of a cancer center.","volume":"26","author":"de Fran\u00e7a","year":"2022","journal-title":"Oral Maxillofac Surg"},{"key":"R41-20250503","first-page":"1455613221115608","article-title":"Survival outcomes related to treatment modalities in patients with oropharyngeal squamous cell carcinoma.","author":"Cheng","year":"2022","journal-title":"Ear Nose Throat J"},{"key":"R42-20250503","doi-asserted-by":"crossref","first-page":"e0211577","DOI":"10.1371\/journal.pone.0211577","article-title":"HPV-driven oropharyngeal squamous cell cancer in Croatia \u2013 demography and survival.","volume":"14","author":"Bo\u017einovi\u0107","year":"2019","journal-title":"PLoS One"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1200\/JCO.2005.04.8306","article-title":"Epidermal growth factor receptor biology in head and neck cancer.","volume":"24","author":"Kalyankrishna","year":"2006","journal-title":"J Clin Oncol"},{"key":"R44-20250503","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","article-title":"Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.","volume":"11","author":"Bonner","year":"2010","journal-title":"Lancet Oncol"},{"key":"R45-20250503","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer.","volume":"359","author":"Vermorken","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038894","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T23:02:55Z","timestamp":1746313375000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038894"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,16]]},"references-count":45,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038894","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,16]]}}}